Imaging-based biomarkers predict PD-L1 and survival outcomes in advanced NSCLC treated with Nivolumab and Pembrolizumab: A multi-institutional study
JTO Clinical and Research Reports(2023)
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要
JTO Clinical and Research Reports(2023)